CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,611,875
- in 1 filing
Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-05 | Davis Robert M EVP, Global Svcs & CFO | Exercise or conversion | +251,273 | 422,328.76 | ||
| 2020-10-05 | Davis Robert M EVP, Global Svcs & CFO | Sale | −251,273 | $81.03 | $20.4M | 171,055.76 |
| 2020-10-05 | Davis Robert M EVP, Global Svcs & CFO | Exercise or conversion · Stock Option (Right to Buy) | −251,273 | 0 | ||
| 2020-09-30 | Seidman Christine E Director | Grant or award · Phantom Stock | +195.9 | $82.95 | $16K | 3,054.24 |
| 2020-09-30 | WENDELL PETER C Director | Grant or award · Phantom Stock | +361.66 | $82.95 | $30K | 98,268.05 |
| 2020-09-30 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +391.8 | $82.95 | $33K | 7,406.43 |
| 2020-08-13 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Sale | −10,380 | $83.01 | $862K | 67,373.36 |
| 2020-08-05 | Clyburn Frank EVP, Chief Commercial Officer | Exercise or conversion | +18,876 | 99,639.11 | ||
| 2020-08-05 | Clyburn Frank EVP, Chief Commercial Officer | Sale | −18,876 | $81.55 | $1.5M | 80,763.11 |
| 2020-08-05 | Clyburn Frank EVP, Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −18,876 | 0 | ||
| 2020-07-17 | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | Exercise or conversion | +18,111 | 62,862.14 | ||
| 2020-07-17 | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | Sale | −18,111 | $80.00 | $1.4M | 44,751.14 |
| 2020-07-17 | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | Sale | −18,174 | $80.01 | $1.5M | 26,577.14 |
| 2020-07-17 | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | Exercise or conversion · Stock Option (Right to Buy) | −18,111 | 0 | ||
| 2020-06-30 | WENDELL PETER C Director | Grant or award · Phantom Stock | +387.95 | $77.33 | $30K | 97,156.53 |
| 2020-06-30 | Seidman Christine E Director | Grant or award · Phantom Stock | +210.14 | $77.33 | $16K | 2,837.98 |
| 2020-06-30 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +420.28 | $77.33 | $32K | 6,963.92 |
| 2020-05-29 | Thulin Inge G Director | Grant or award · Phantom Stock | +2,477.7 | $80.72 | $200K | 10,326.03 |
| 2020-05-29 | Warden Kathy J Director | Grant or award · Phantom Stock | +2,477.7 | $80.72 | $200K | 2,591.5 |
| 2020-05-29 | WENDELL PETER C Director | Grant or award · Phantom Stock | +2,477.7 | $80.72 | $200K | 96,768.58 |
Page 48 of 52 · 1,021 trades